is semaglutide a diabetes drug Type 2 improves weight loss, blood sugar in certain Type 1 patients with obesity FDA Warns on Certain Forms

However, these explorations remain investigational and have not resulted in FDA approval for doses exceeding the 2.4 mg weekly standard for weight management

If you are weighing that, treat it as one option within a wider strategy, and talk with your clinician or pharmacist before adding anything while on GLP-1 therapy

Unfortunately, there aren't inherently "preferable" alcoholic beverages while taking Ozempic

Researchers also looked at the risk that patients might be diagnosed with biliary disease, which is a cluster of problems affecting the gallbladder and bile ducts, but there were no significant differences between the groups

Fatima Cody Stanford, an obesity medicine physician at Massachusetts General Hospital in Boston and an associate professor of medicine and pediatrics at Harvard Medical School

Cell 182 , 12711283 (2020)